Medicine & Life Sciences
Prostatic Neoplasms
100%
Renal Cell Carcinoma
69%
Neoplasms
68%
Castration
28%
Therapeutics
28%
Neoplasm Metastasis
27%
Survival
25%
Urinary Bladder Neoplasms
25%
Carcinoma
23%
Prostate
23%
Drug Therapy
22%
Androgens
20%
Nivolumab
17%
Immunotherapy
16%
Genes
15%
Sunitinib
14%
Growth
13%
Ipilimumab
13%
Bone and Bones
13%
Cell Line
12%
Androgen Receptors
12%
Ligands
12%
Biomarkers
11%
Progression-Free Survival
11%
Prostate-Specific Antigen
11%
Retinoblastoma
11%
Bacteriophages
11%
Mutation
11%
Proteins
10%
Kidney Neoplasms
10%
Caveolin 1
10%
Urinary Bladder
9%
Peptides
9%
Docetaxel
9%
Cisplatin
9%
Bone Neoplasms
9%
cabozantinib
9%
Clinical Trials
9%
T-Lymphocytes
9%
Tumor Microenvironment
9%
Adenocarcinoma
8%
Recurrence
8%
Confidence Intervals
8%
CCAAT-Binding Factor
8%
Abiraterone Acetate
8%
Doxorubicin
8%
Heterografts
8%
Vascular Endothelial Growth Factor A
7%
DNA
7%
Nephrectomy
7%
src-Family Kinases
7%
Apoptosis
7%
Interferons
7%
Kidney
7%
Protein-Tyrosine Kinases
7%
Melanoma
7%
Germ Cell and Embryonal Neoplasms
7%
Safety
7%
Everolimus
7%
In Vitro Techniques
6%
Genetic Therapy
6%
Integrins
6%
MDV 3100
6%
Gene Expression
6%
Carcinogenesis
6%
Endothelial Cells
6%
Phenotype
6%
Genome
5%
Colorectal Neoplasms
5%
Clear-cell metastatic renal cell carcinoma
5%
Prednisone
5%
Testicular Neoplasms
5%
Small Cell Carcinoma
5%
Chromosomes
5%
pembrolizumab
5%
Prostatectomy
5%
Watchful Waiting
5%
Serum
5%
Disease Progression
5%
Breast Neoplasms
5%
Lymph Nodes
5%
Nude Mice
5%
gemcitabine
5%
von Hippel-Lindau Disease
5%
pazopanib
5%
Radiotherapy
5%
Transitional Cell Carcinoma
5%
Nonseminomatous germ cell tumor
5%